Home / Triamcinolone / Canada
CA ATC H02AB08 · updated 2 Nov 2026
Triamcinolone shortage in Canada
Is there a Triamcinolone shortage in Canada?
Yes. As of 2 Nov 2026, 4 Triamcinolone products are reported short in Canada, the first since 16 Apr 2025. The company estimate for the return is 31 Jan 2027. Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Belgium, Czechia, Norway, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | KENALOG-40 INJECTION (5ML & 1ML) | BRISTOL-MYERS SQUIBB CANADA | 16 Apr 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | KENALOG-10 INJECTION (5ML) | BRISTOL-MYERS SQUIBB CANADA | 13 Jun 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP (10 VIALS X 5 ML) | STERIMAX INC | 27 Aug 2025 | 31 Jan 2027 | Distribution or logistics Delay in shipping of the drug |
| CA | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP (1 ML) | STERIMAX INC | 3 Feb 2026 | 31 Jan 2027 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.